Teruhiko TerasawaSummaryAffiliation: Tufts-New England Medical Center Country: USA |
Detail Information
Publications
18F-FDG PET for posttherapy assessment of Hodgkin's disease and aggressive Non-Hodgkin's lymphoma: a systematic reviewTeruhiko Terasawa
Clinical Research Center for Blood Diseases, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
J Nucl Med 49:13-21. 2008..The aim of this study was to systematically review the diagnostic accuracy of (18)F-FDG PET in detecting residual disease at the completion of first-line therapy of Hodgkin's disease (HD) and aggressive non-Hodgkin's lymphoma (NHL)...
